BCSCP study guide
BCSCP · Work through your exam, one topic at a time.
The Board Certified Sterile Compounding Pharmacist (BCSCP) credential is a specialty certification for pharmacists who prepare or oversee compounded sterile preparations - IV admixtures, injectables, ophthalmic and irrigation products - in hospitals, infusion centers, home infusion services, and outsourcing facilities. It is distinct from licensure: it signals that a practitioner has demonstrated, through a psychometrically developed examination, depth of knowledge beyond entry-level practice. The BCSCP study guide has 6 sections and about 1,755 words.
01Sterile Compounding Process and Technique
Sterile compounding is judged by control of the process, not by the appearance of the final container. The 2023 revision of USP <797 replaced the older low/medium/high-risk framework with Category 1, 2, and 3 CSPs, each with its own maximum beyond-use date (BUD); the category follows from how the CSP is prepared and sterilized, not from the drug or the patient.
304 words, about 2 min02Facilities, Equipment, and Environmental Monitoring
The physical hierarchy is ISO 5 at the primary engineering control (PEC - LAFW, BSC, CAI, CACI), ISO 7 in the buffer area, and ISO 8 in the ante-area where garbing occurs. A segregated compounding area (SCA) is a permitted alternative for lower-category work but carries restricted BUDs and no buffer/ante separation.
303 words, about 2 min03Quality Assurance and Quality Control
Quality assurance is the whole framework - SOPs, training records, validation, audits, deviation handling, CAPA, change control, and management review. Quality control is the measurement: environmental monitoring results, media fills, gloved fingertip results, end-product testing, and release inspection.
290 words, about 1 min04Personnel Training, Competency Assessment, and Safety
Personnel must be trained before touching a PEC and verified competent before compounding independently. Initial training typically combines didactic content (microbiology, contamination sources, USP <797 requirements, calculations, hazardous drugs), demonstration, and supervised practice, followed by documented competency: visual observation of hand hygiene and garbing, aseptic technique, and sharps handling; gloved fingertip and thumb sampling; and a media fill.
283 words, about 1 min05Hazardous Drug Handling and Related Regulations
USP <800 applies wherever hazardous drugs (HDs) are handled - receiving, storage, compounding, administration, waste, and spill control - and it is not limited to oncology. The NIOSH list organizes HDs into Table 1 (antineoplastic), Table 2 (non-antineoplastic), and Table 3 (reproductive risk at low doses); the list must be reviewed at least every 12 months and the facility's own HD list maintained.
299 words, about 1 min06Patient Safety, Risk Management, and Continuous Quality Improvement
Patient safety in compounding rests on systems: standardized concentrations and bases, limited formularies, ready-to-use products, barcode verification, smart-pump libraries, independent double checks for high-alert medications, and removal of error-prone abbreviations. Error reporting must be nonpunitive at the front line - a just culture distinguishes human error, at-risk behavior, and reckless behavior - because reporting is the raw material of improvement.
276 words, about 1 min